News-Papers
Testimonial
Video Gallery
Clinical importance of melatonin
Published on Tuesday, 26 June 2018
Clinical importance of melatonin
See also:
- The Di Bella Method (A Fixed Part - Melatonin tablets);
- Complete objective response to biological therapy of plurifocal breast carcinoma.
Search
Follow us...
Latest
- Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
- Somatostatin and Somatostatin Receptors in Tumour Biology
- Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
- Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation
- Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
- High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
- Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
- Melatonin and its ubiquitous anticancer effects
- Radioprotective effects of melatonin on radiation-induced cataract
- Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis
- Prolactin inhibitors in oncology
- Somatostatin in oncology, the overlooked evidences
- Melatonin Ameliorates The Production of COX-2, iNOS, and The Formation of 8-OHdG in Non-Targeted Lung Tissue after Pelvic Irradiation
- Neurobiology. Receptors as kissing cousins
- Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity
- Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/ Rac/PAK signaling pathway in breast cancer cells
- Plasma melatonin and the hormone-dependency of human breast cancer
- Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer